Melanopsin (Opsin-4) (OPN4)

Blue light (400-500 nm) at the retina and macula acts as a critical environmental signal for both visual and non-visual physiological processes. The primary molecular receptor for blue light in the retina is Melanopsin (OPN4), a G protein-coupled receptor expressed in intrinsically photosensitive retinal ganglion cells (ipRGCs). Melanopsin is maximally sensitive to wavelengths around 480 nm and mediates the synchronization of the circadian clock, the pupillary light reflex, and the suppression of melatonin. In the macula, blue light is primarily filtered by macular pigments (lutein, zeaxanthin, and meso-zeaxanthin) to protect the underlying retinal pigment epithelium (RPE) and photoreceptors from photochemical damage and oxidative stress. Excessive exposure to high-energy blue light is associated with the blue light hazard, which may contribute to the pathogenesis of age-related macular degeneration (AMD) through the generation of reactive oxygen species (ROS) and the activation of apoptotic pathways in RPE cells. Therapeutic interventions include the use of blue-light filtering lenses, antioxidant supplements (macular pigments), and experimental melanopsin modulators to manage sleep disorders and photophobia.

Other names

Opsin-4OPN4Blue-light receptoripRGC photopigmentMacular pigment (related)Blue light hazard (related)

Melanopsin (OPN4) is a G protein-coupled receptor that absorbs blue light (peak ~480 nm), triggering a Gq/11-mediated signaling cascade that depolarizes intrinsically photosensitive retinal ganglion cells (ipRGCs). This signal is transmitted to the suprachiasmatic nucleus (SCN) to regulate circadian rhythms and to the pretectal area for the pupillary light reflex. In the macula, blue light is filtered by carotenoids (lutein/zeaxanthin) to prevent oxidative damage to the RPE. Drugs targeting this pathway either antagonize OPN4 to manage photophobia and sleep or supplement macular pigments to provide photoprotection.